Status:

TERMINATED

Promoting Activity After COPD Exacerbations, Aim 2

Lead Sponsor:

University of Illinois at Chicago

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This randomized controlled pilot study involving patients with chronic obstructive pulmonary disease (COPD) recently discharged from the hospital will evaluate the feasibility and efficacy of a home-b...

Detailed Description

Deconditioning is common in patients with chronic obstructive pulmonary disease (COPD) and has been associated with poor outcomes (e.g. difficulty breathing). Pulmonary rehabilitation (PR) initiated s...

Eligibility Criteria

Inclusion

  • Age 18 years or older;
  • Physician diagnosis of COPD;
  • Hospitalized as an inpatient, 23-hour observation, or clinical decision unit
  • Admitting respiratory conditions sensitive to the Centers for Medicare and Medicaid Services Hospital Readmission Reduction Program as listed below:
  • COPD exacerbation
  • Asthma/COPD overlap
  • Decompensated heart failure
  • Pneumonia
  • Chronic Airway Disease

Exclusion

  • Physical inability to participate in a walking program;
  • Oxygen saturation \<90% by pulse oximetry refractory to supplemental oxygen, or in a patient unable or unwilling to use supplemental oxygen;
  • Fall in the previous 6 months;
  • Resting electrocardiogram (ECG) with new ST changes or tachyarrhythmia;
  • Planned discharge home to hospice or to long term care facility/skilled nursing facility;
  • Life expectancy \<3 months;
  • Medical contraindication to participating in a physical activity promotion program as determined by the inpatient treating clinician;
  • Unable to communicate in English;
  • Unable or declines to provide informed consent.

Key Trial Info

Start Date :

March 18 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 8 2022

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT03793192

Start Date

March 18 2019

End Date

April 8 2022

Last Update

January 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Illinois at Chicago

Chicago, Illinois, United States, 60612